That cooperative effort, linked with the WHO, would allow nations to take advantage of a portfolio of potential vaccines to ensure their citizens are quickly covered by whichever ones are deemed effective

The trial is being conducted under U.S. government's Operation Warp Speed program, which aims to accelerate development, manufacturing and distribution of vaccines and treatments for COVID-19

Many experts expressed skepticism about the Russian vaccine after the government declared its intention to give it to high-risk groups in October without data from large pivotal trials

The company is working on two of the more than 150 potential vaccines being developed across the world to tackle the COVID-19 pandemic

Coronavirus vaccine update: 'We are delivering life-saving therapies and (we) will produce a vaccine before the end of this year or maybe even sooner. We will defeat the virus and the pandemic,' US President Donald Trump said

China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), also said it had obtained emergency use approval for a coronavirus vaccine candidate

More than 180,000 people have died from the coronavirus pandemic since the start of the outbreak in the US, according to a tally by Johns Hopkins University

Health officials have been concerned about whether vaccine candidates would work in older people, whose immune systems typically do not respond as strongly to vaccines

Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report

Coronavirus vaccine update: Phase 2 trials of Oxford coronavirus vaccine, being manufactured by Serum Institute of India (SII), have begun in India

Coronavirus vaccine news update: Russian Ambassador Nikolai Kudashev reached out to India on Tuesday seeking a partnership in the production of coronaviru vaccine Sputnik V

There are no approved vaccines for COVID-19, but AstraZeneca's shot, called AZD1222, is widely seen as one of the leading candidates

One month has passed since China officially launched the urgent use of COVID-19 vaccines on July 22, while the vaccines were going through clinical trials

The vaccine, developed by West China Hospital of Sichuan University in Chengdu, has received approval from the National Medical Products Administration to conduct human clinical trials

The vaccine, developed by West China Hospital of Sichuan University in Chengdu, has received approval from the National Medical Products Administration to conduct human clinical trials

Indonesia has recorded 147,211 coronavirus infections and 6,418 deaths and is keen to secure a vaccine for its 260 million people and develop its own, amid concern among some developing countries about competition for access

Coronavirus vaccine update: Serum Institute of India that is manufacturing the Oxford University-AstraZeneca vaccine will conductt the trials wouldon 1,600 healthy volunteers with no history of COVID-19

RDIF CEO Kirill Dmitriev said that Russia currently has the capacity of 500 million doses per year, but plans to increase this capacity

Coronavirus vaccine news update: Oxford vaccine could be the first antidote to be released in India. Bharat Biotech's COVAXIN and Zydus Cadila's ZyCoV-D are in initial stages of trials

COVID-19 pandemic: WHO lambasts 'vaccine nationalism' in last-resort attempt against hoardingNations that hoard possible COVID-19 vaccines while excluding others will deepen the pandemic, World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus said on Tuesday, issuing a last-ditch call for countries to join a global vaccine pact. The WHO has an Aug. 31 deadline for wealthier nations to join the \"COVAX Global Vaccines Facility\" for sharing vaccine hopefuls with developing countries...